ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE was reported 6334 times

ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VENOLYMPHATIC MALFORMATION 7 0.6364
1 MYCOPLASMA GENITALIUM INFECTION 9 0.4737
2 CHEMOTHERAPEUTIC DRUG LEVEL DECREASED 3 0.2727
3 PROCTITIS CHLAMYDIAL 3 0.2727
4 RETROVIRAL REBOUND SYNDROME 3 0.1304
5 ULTRASOUND UTERUS ABNORMAL 5 0.0943
6 BONE DEMINERALISATION 97 0.0916
7 POLYMICROGYRIA 4 0.0889
8 AMNIOTIC FLUID INDEX DECREASED 3 0.0833
9 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 9 0.0811
10 TESTICULAR OPERATION 4 0.0714
11 CEREBRAL DYSGENESIS 4 0.0667
12 CAUDAL REGRESSION SYNDROME 10 0.0641
13 BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL 3 0.0638
14 BLOOD HIV RNA 3 0.0577
15 VIRAL LOAD UNDETECTABLE 3 0.0536
16 JOINT MICROHAEMORRHAGE 3 0.0429
17 BLOOD HIV RNA INCREASED 77 0.0424
18 FEAR-RELATED AVOIDANCE OF ACTIVITIES 6 0.0395
19 RENAL HYPOPLASIA 8 0.0367
20 INTERFERON GAMMA RELEASE ASSAY POSITIVE 6 0.0366
21 SYRINGOMYELIA 10 0.0360
22 VIRAL LOAD DECREASED 5 0.0342
23 CD4 LYMPHOCYTES ABNORMAL 7 0.0333
24 MONKEYPOX 9 0.0326
25 AIDS RELATED COMPLICATION 2 0.0308
26 MENINGOCELE 4 0.0255
27 ANHEDONIA 628 0.0239
28 RETROPLACENTAL HAEMATOMA 4 0.0231
29 QUADRANTANOPIA 3 0.0229
30 ACUTE HEPATITIS B 7 0.0211
31 BETA 2 MICROGLOBULIN URINE INCREASED 3 0.0210
32 AGONAL RHYTHM 2 0.0206
33 OESOPHAGEAL SQUAMOUS CELL CARCINOMA 5 0.0204
34 ANOGENITAL DYSPLASIA 3 0.0200
35 FANCONI SYNDROME ACQUIRED 34 0.0194
36 ACQUIRED IMMUNODEFICIENCY SYNDROME 10 0.0193
37 HIV VIRAEMIA 4 0.0190
38 ACUTE ON CHRONIC LIVER FAILURE 4 0.0185
39 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 5 0.0185
40 LIPOEDEMA 7 0.0178
41 VIRAL LOAD INCREASED 68 0.0175
42 ACUTE CARDIAC EVENT 3 0.0174
43 VIRAL LOAD 3 0.0173
44 VIRAL LOAD ABNORMAL 3 0.0171
45 SYPHILIS 12 0.0165
46 BLADDER REPAIR 3 0.0164
47 NIPPLE SWELLING 4 0.0159
48 ECONOMIC PROBLEM 230 0.0152
49 VARICOCELE 4 0.0152
50 CENTRAL NERVOUS SYSTEM INFLAMMATION 5 0.0151
51 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0136
52 CD4 LYMPHOCYTES INCREASED 3 0.0129
53 PRIMARY BILIARY CHOLANGITIS 6 0.0128
54 OSTEOPENIA 191 0.0126
55 LARYNGOMALACIA 4 0.0119
56 HYPERHOMOCYSTEINAEMIA 3 0.0115
57 GONORRHOEA 3 0.0111
58 TEMPERATURE REGULATION DISORDER 24 0.0108
59 CD4 LYMPHOCYTES DECREASED 23 0.0107
60 VIRAL MUTATION IDENTIFIED 39 0.0106
61 MENTAL DISABILITY 6 0.0104
62 FOETAL DEATH 50 0.0096
63 LIPODYSTROPHY ACQUIRED 20 0.0094
64 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 44 0.0088
65 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
66 BONE DENSITY DECREASED 257 0.0082
67 SITTING DISABILITY 5 0.0081
68 ENDOCARDITIS STAPHYLOCOCCAL 4 0.0081
69 ABORTION THREATENED 4 0.0080
70 ADENOTONSILLECTOMY 2 0.0080
71 FAT TISSUE DECREASED 3 0.0077
72 VIROLOGIC FAILURE 41 0.0076
73 PRODUCT LABEL ON WRONG PRODUCT 3 0.0076
74 T-LYMPHOCYTE COUNT DECREASED 5 0.0073
75 OSTEOPOROSIS 282 0.0068
76 GENOTYPE DRUG RESISTANCE TEST POSITIVE 7 0.0068
77 DEGENERATIVE BONE DISEASE 3 0.0068
78 ANOGENITAL WARTS 6 0.0067
79 NEUROPSYCHIATRIC SYMPTOMS 6 0.0066
80 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 7 0.0065
81 ADRENAL NEOPLASM 3 0.0064
82 GLOMERULAR FILTRATION RATE ABNORMAL 9 0.0064
83 LIP DISCOLOURATION 8 0.0063
84 CHRONIC KIDNEY DISEASE 473 0.0062
85 BRONCHOPULMONARY DYSPLASIA 5 0.0062
86 SHOULDER FRACTURE 10 0.0061
87 MULTIPLE FRACTURES 97 0.0059
88 POLYHYDRAMNIOS 6 0.0059
89 GLARE 3 0.0058
90 OSTEOMALACIA 9 0.0058
91 EMOTIONAL DISTRESS 697 0.0058
92 CRYPTOSPORIDIOSIS INFECTION 3 0.0057
93 BODY FAT DISORDER 3 0.0055
94 NEURAL TUBE DEFECT 4 0.0055
95 END STAGE RENAL DISEASE 100 0.0055
96 BONE LOSS 82 0.0054
97 COMPLICATION OF PREGNANCY 4 0.0053
98 LIPOATROPHY 5 0.0053
99 DYSMORPHISM 12 0.0051
100 PATHOGEN RESISTANCE 44 0.0048
101 HYPERPARATHYROIDISM SECONDARY 12 0.0048
102 HEPATITIS A 4 0.0047
103 HIV INFECTION 14 0.0046
104 ABDOMINAL LYMPHADENOPATHY 4 0.0046
105 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 4 0.0046
106 DECREASED ACTIVITY 49 0.0045
107 NEONATAL DISORDER 7 0.0044
108 QUALITY OF LIFE DECREASED 59 0.0044
109 AGORAPHOBIA 6 0.0044
110 VIRAEMIA 6 0.0043
111 CRANIAL NERVE DISORDER 3 0.0043
112 FANCONI SYNDROME 6 0.0042
113 ATYPICAL MYCOBACTERIAL INFECTION 6 0.0042
114 HAND FRACTURE 30 0.0042
115 TOOTH LOSS 87 0.0042
116 RENAL TRANSPLANT 15 0.0041
117 RENAL TUBULAR INJURY 5 0.0041
118 VITAMIN D DEFICIENCY 40 0.0041
119 NEPHROPATHY 38 0.0041
120 HEMIANOPIA 4 0.0040
121 TRISOMY 21 5 0.0040
122 CHLAMYDIAL INFECTION 3 0.0040
123 HYPERTENSIVE NEPHROPATHY 4 0.0037
124 BONE DENSITY ABNORMAL 14 0.0037
125 HEPATITIS VIRAL 3 0.0037
126 SKELETAL INJURY 38 0.0037
127 MITOCHONDRIAL TOXICITY 3 0.0037
128 DYSLIPIDAEMIA 18 0.0035
129 OSTEONECROSIS 114 0.0035
130 METHAEMOGLOBINAEMIA 8 0.0035
131 FAT TISSUE INCREASED 5 0.0034
132 PORTAL VEIN THROMBOSIS 11 0.0034
133 MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0033
134 MULTIMORBIDITY 4 0.0033
135 FOOD ALLERGY 25 0.0032
136 FRACTURED SACRUM 4 0.0032
137 CEREBRAL TOXOPLASMOSIS 3 0.0032
138 TESTICULAR SWELLING 4 0.0032
139 PROTEIN TOTAL ABNORMAL 4 0.0031
140 ULNA FRACTURE 3 0.0030
141 FOOT FRACTURE 57 0.0030
142 GASTRECTOMY 3 0.0030
143 LIPIDS INCREASED 6 0.0030
144 BLOOD CREATININE INCREASED 194 0.0030
145 HYPERPARATHYROIDISM 6 0.0029
146 FACTOR VIII INHIBITION 3 0.0029
147 PRODUCT DOSE OMISSION ISSUE 827 0.0028
148 PROTEIN URINE PRESENT 14 0.0028
149 KIDNEY ENLARGEMENT 3 0.0028
150 PRODUCT DOSE OMISSION IN ERROR 78 0.0028
151 GESTATIONAL DIABETES 13 0.0027
152 TOBACCO USER 4 0.0027
153 STENOSIS 5 0.0027
154 ANXIETY 757 0.0027
155 RENAL COLIC 6 0.0027
156 THYROTOXIC CRISIS 3 0.0026
157 FOETAL GROWTH RESTRICTION 16 0.0026
158 OSTEOPOROTIC FRACTURE 5 0.0026
159 EXERCISE TOLERANCE DECREASED 15 0.0026
160 DYSLEXIA 3 0.0026
161 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
162 DAYDREAMING 4 0.0026
163 NEPHROGENIC ANAEMIA 12 0.0026
164 SUBSTANCE USE 4 0.0026
165 PSYCHIATRIC DECOMPENSATION 5 0.0026
166 CACHEXIA 13 0.0025
167 RENAL IMPAIRMENT 212 0.0025
168 EXPOSURE DURING PREGNANCY 156 0.0025
169 ABORTION INDUCED 23 0.0024
170 FIBULA FRACTURE 7 0.0024
171 ADRENAL MASS 2 0.0024
172 LIVE BIRTH 20 0.0024
173 RENAL INJURY 71 0.0024
174 GASTRIC ULCER PERFORATION 3 0.0024
175 TROPONIN T INCREASED 3 0.0024
176 COELIAC DISEASE 23 0.0023
177 RENAL FAILURE 309 0.0023
178 NAIL DISCOLOURATION 9 0.0023
179 MENINGITIS CRYPTOCOCCAL 4 0.0023
180 PRODUCT DOSE OMISSION 147 0.0022
181 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
182 FACIAL BONES FRACTURE 8 0.0022
183 INABILITY TO AFFORD MEDICATION 22 0.0022
184 DRUG SCREEN FALSE POSITIVE 6 0.0022
185 PROTEINURIA 41 0.0022
186 TIBIA FRACTURE 10 0.0021
187 HEPATIC NECROSIS 8 0.0021
188 DYSSTASIA 62 0.0021
189 MECHANICAL VENTILATION 4 0.0021
190 CEREBELLAR HAEMORRHAGE 3 0.0021
191 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 3 0.0021
192 GENE MUTATION 4 0.0020
193 PATENT DUCTUS ARTERIOSUS 8 0.0020
194 CAROTID ARTERY STENOSIS 7 0.0020
195 HEPATITIS B 12 0.0020
196 HEPATITIS C 24 0.0020
197 ECTOPIC PREGNANCY 6 0.0019
198 HYPERURICAEMIA 8 0.0019
199 RENAL TUBULAR NECROSIS 19 0.0019
200 SPINAL COMPRESSION FRACTURE 16 0.0019
201 LIVER TRANSPLANT 7 0.0019
202 WRIST FRACTURE 23 0.0019
203 PERSONALITY DISORDER 5 0.0019
204 INTESTINAL OPERATION 3 0.0019
205 TESTICULAR PAIN 6 0.0019
206 HEPATITIS B REACTIVATION 6 0.0019
207 BURSITIS 22 0.0018
208 TONSILLAR HYPERTROPHY 3 0.0018
209 ENDOTRACHEAL INTUBATION 5 0.0018
210 FEAR OF DEATH 4 0.0018
211 RIB FRACTURE 36 0.0017
212 LYMPHOMA 27 0.0017
213 MULTIPLE INJURIES 11 0.0017
214 REGURGITATION 6 0.0017
215 SPINAL FUSION SURGERY 7 0.0017
216 AUTOIMMUNE HEPATITIS 12 0.0017
217 COLITIS MICROSCOPIC 8 0.0017
218 APPENDICECTOMY 6 0.0017
219 RADIUS FRACTURE 4 0.0017
220 EMERGENCY CARE 5 0.0016
221 POST-TRAUMATIC STRESS DISORDER 11 0.0016
222 ESSENTIAL HYPERTENSION 3 0.0016
223 INJECTION SITE ABSCESS 4 0.0016
224 HYPERTENSIVE HEART DISEASE 3 0.0016
225 RENAL PAIN 17 0.0016
226 ABORTION MISSED 2 0.0016
227 HEPATOSPLENOMEGALY 4 0.0016
228 TREATMENT NONCOMPLIANCE 85 0.0016
229 IMMUNODEFICIENCY 23 0.0015
230 HEPATITIS ACUTE 10 0.0015
231 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
232 IMMUNE THROMBOCYTOPENIA 7 0.0015
233 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
234 RENAL CYST 12 0.0015
235 INTENTIONAL UNDERDOSE 11 0.0015
236 AZOTAEMIA 6 0.0015
237 CORONARY ARTERY THROMBOSIS 3 0.0015
238 MUSCLE CONTRACTURE 3 0.0015
239 SKIN WRINKLING 4 0.0015
240 OSTEOLYSIS 3 0.0015
241 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9 0.0015
242 SPINAL PAIN 17 0.0014
243 SOCIAL PROBLEM 6 0.0014
244 DIABETIC COMA 4 0.0014
245 PROCTITIS 4 0.0014
246 URINARY BLADDER HAEMORRHAGE 3 0.0014
247 RENAL TUBULAR DISORDER 4 0.0014
248 ANKLE FRACTURE 22 0.0014
249 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
250 HEART DISEASE CONGENITAL 5 0.0014
251 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
252 HYPERPHOSPHATAEMIA 3 0.0014
253 PNEUMOCYSTIS JIROVECII PNEUMONIA 14 0.0014
254 JAW FRACTURE 3 0.0014
255 DEPRESSION 315 0.0014
256 LOW BIRTH WEIGHT BABY 11 0.0014
257 OCULAR ICTERUS 6 0.0014
258 ABORTION 4 0.0014
259 LUMBAR SPINAL STENOSIS 4 0.0014
260 TOOTH FRACTURE 15 0.0014
261 RETROPERITONEAL HAEMATOMA 3 0.0014
262 IMPAIRED WORK ABILITY 29 0.0014
263 BLOOD CREATINE INCREASED 6 0.0014
264 NERVE INJURY 15 0.0013
265 PARESIS 3 0.0013
266 ACUTE KIDNEY INJURY 203 0.0013
267 DRUG RESISTANCE 34 0.0013
268 URINE ABNORMALITY 6 0.0013
269 PERIARTHRITIS 3 0.0013
270 POLLAKIURIA 55 0.0013
271 PAIN 809 0.0013
272 BLOOD TESTOSTERONE DECREASED 9 0.0013
273 HIP ARTHROPLASTY 20 0.0013
274 PRODUCT SIZE ISSUE 7 0.0013
275 STRESS FRACTURE 7 0.0013
276 INTERCEPTED MEDICATION ERROR 6 0.0013
277 BEHAVIOUR DISORDER 7 0.0013
278 PRODUCT DISPENSING ERROR 28 0.0013
279 FRACTURE 24 0.0013
280 DRUG SCREEN POSITIVE 10 0.0013
281 PRE-ECLAMPSIA 6 0.0013
282 FOETAL EXPOSURE DURING PREGNANCY 102 0.0013
283 SPINAL OSTEOARTHRITIS 11 0.0013
284 CUSHINGOID 4 0.0012
285 PURPURA 11 0.0012
286 PRESCRIBED OVERDOSE 24 0.0012
287 RENAL DISORDER 57 0.0012
288 THERAPY CHANGE 12 0.0012
289 PSYCHIATRIC SYMPTOM 9 0.0012
290 HYPOPHOSPHATAEMIA 9 0.0012
291 MOUTH SWELLING 7 0.0012
292 ACUTE PSYCHOSIS 3 0.0012
293 NEAR DEATH EXPERIENCE 4 0.0012
294 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
295 HYPERTRIGLYCERIDAEMIA 7 0.0012
296 PREMATURE DELIVERY 19 0.0012
297 EXPOSURE VIA INGESTION 3 0.0012
298 HAEMODYNAMIC INSTABILITY 9 0.0012
299 HYPERLIPIDAEMIA 14 0.0012
300 INTERVERTEBRAL DISC DISORDER 5 0.0012
301 INFARCTION 8 0.0012
302 PHYSICAL DECONDITIONING 3 0.0012
303 BLOOD CREATININE ABNORMAL 4 0.0012
304 DEPRESSIVE SYMPTOM 4 0.0011
305 HEPATIC STEATOSIS 21 0.0011
306 INTENTIONAL DOSE OMISSION 31 0.0011
307 EOSINOPHILIC OESOPHAGITIS 3 0.0011
308 DRUG LEVEL DECREASED 11 0.0011
309 HEPATIC ENCEPHALOPATHY 10 0.0011
310 HYPERTONIC BLADDER 3 0.0010
311 NEPHROLITHIASIS 47 0.0010
312 IMMUNOSUPPRESSION 9 0.0010
313 PRODUCT USE COMPLAINT 16 0.0010
314 BIPOLAR DISORDER 11 0.0010
315 NIGHTMARE 35 0.0010
316 POLYNEUROPATHY 12 0.0010
317 INTRACRANIAL ANEURYSM 4 0.0010
318 CORONARY ARTERY STENOSIS 5 0.0010
319 CRANIOCEREBRAL INJURY 3 0.0010
320 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
321 MOBILITY DECREASED 71 0.0010
322 BONE DISORDER 18 0.0010
323 CEREBRAL ISCHAEMIA 5 0.0010
324 SPINAL STENOSIS 4 0.0010
325 SCOLIOSIS 6 0.0010
326 JAUNDICE 26 0.0010
327 DRUG-INDUCED LIVER INJURY 30 0.0010
328 DERMATITIS ALLERGIC 12 0.0010
329 ACUTE MYOCARDIAL INFARCTION 28 0.0009
330 BLOOD LACTIC ACID INCREASED 5 0.0009
331 MENTAL DISORDER 41 0.0009
332 HEPATIC ENZYME INCREASED 64 0.0009
333 VENTRICULAR HYPOKINESIA 3 0.0009
334 ANAL FISSURE 5 0.0009
335 LOOSE TOOTH 3 0.0009
336 HIP SURGERY 5 0.0009
337 TOOTH INJURY 4 0.0009
338 LYMPHOCYTE COUNT INCREASED 3 0.0009
339 DYSPHEMIA 4 0.0009
340 SUSPECTED COVID-19 3 0.0009
341 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
342 MENINGITIS 6 0.0009
343 SPINAL FRACTURE 18 0.0009
344 HAEMOLYTIC ANAEMIA 8 0.0009
345 LIVER FUNCTION TEST INCREASED 19 0.0009
346 LOWER LIMB FRACTURE 17 0.0009
347 ABNORMAL DREAMS 24 0.0009
348 PRODUCT USE ISSUE 162 0.0009
349 RENAL FUNCTION TEST ABNORMAL 4 0.0009
350 UPPER LIMB FRACTURE 17 0.0009
351 INSOMNIA 227 0.0009
352 RASH GENERALISED 22 0.0008
353 ABORTION SPONTANEOUS 34 0.0008
354 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0008
355 HYPOVOLAEMIC SHOCK 4 0.0008
356 SUBCUTANEOUS ABSCESS 4 0.0008
357 LIMB OPERATION 4 0.0008
358 ILL-DEFINED DISORDER 50 0.0008
359 ALCOHOL USE 3 0.0008
360 ARTHROPOD BITE 6 0.0008
361 ABDOMINAL TENDERNESS 4 0.0008
362 CHRONIC SINUSITIS 3 0.0008
363 CHEMOTHERAPY 3 0.0008
364 TENDON PAIN 6 0.0008
365 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
366 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
367 MYOCARDITIS 9 0.0008
368 DRUG DISPENSING ERROR 12 0.0008
369 BOWEL MOVEMENT IRREGULARITY 6 0.0008
370 CLAVICLE FRACTURE 3 0.0008
371 ABDOMINAL INFECTION 2 0.0008
372 PRODUCT STORAGE ERROR 68 0.0008
373 HYPERBILIRUBINAEMIA 8 0.0008
374 MUSCLE RUPTURE 3 0.0008
375 HALLUCINATION, AUDITORY 12 0.0008
376 ALCOHOL ABUSE 2 0.0007
377 MUSCLE HAEMORRHAGE 3 0.0007
378 SUICIDAL IDEATION 68 0.0007
379 ABDOMINAL RIGIDITY 2 0.0007
380 LIVER INJURY 18 0.0007
381 ABNORMAL FAECES 6 0.0007
382 OSTEOARTHRITIS 31 0.0007
383 NEPHROTIC SYNDROME 5 0.0007
384 LEG AMPUTATION 3 0.0007
385 GAIT DISTURBANCE 139 0.0007
386 ENCEPHALITIS 5 0.0007
387 CONGESTIVE CARDIOMYOPATHY 3 0.0007
388 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
389 NEPHROPATHY TOXIC 8 0.0007
390 PSYCHOTIC DISORDER 21 0.0007
391 BUNDLE BRANCH BLOCK LEFT 3 0.0007
392 BONE PAIN 41 0.0007
393 HYPERTONIA 4 0.0007
394 HERPES VIRUS INFECTION 4 0.0007
395 HEPATIC CIRRHOSIS 13 0.0007
396 HYPERKALAEMIA 24 0.0007
397 HOSPITALISATION 105 0.0007
398 PRODUCT COMMUNICATION ISSUE 6 0.0007
399 TRANSAMINASES INCREASED 15 0.0007
400 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
401 NOCTURIA 8 0.0007
402 HAEMOGLOBIN INCREASED 3 0.0007
403 TROPONIN INCREASED 5 0.0007
404 DYSURIA 24 0.0007
405 LOCALISED OEDEMA 3 0.0006
406 DRUG DOSE OMISSION 107 0.0006
407 CONGENITAL ANOMALY 5 0.0006
408 FLANK PAIN 6 0.0006
409 LIVER DISORDER 28 0.0006
410 METABOLIC ACIDOSIS 20 0.0006
411 PANCREATITIS 33 0.0006
412 HUMERUS FRACTURE 3 0.0006
413 STILLBIRTH 3 0.0006
414 INTENTIONAL PRODUCT MISUSE 54 0.0006
415 SUBSTANCE ABUSE 5 0.0006
416 MUCOSAL INFLAMMATION 16 0.0006
417 DYSGRAPHIA 4 0.0006
418 RASH ERYTHEMATOUS 29 0.0006
419 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
420 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
421 ACUTE CORONARY SYNDROME 5 0.0006
422 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
423 ERYSIPELAS 3 0.0006
424 FEAR 16 0.0006
425 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
426 WRONG PRODUCT ADMINISTERED 4 0.0006
427 HAEMATEMESIS 15 0.0006
428 DIABETES MELLITUS 45 0.0006
429 PETIT MAL EPILEPSY 3 0.0006
430 HEPATITIS 15 0.0006
431 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
432 ACUTE HEPATIC FAILURE 8 0.0006
433 THERAPY CESSATION 30 0.0006
434 HEPATOTOXICITY 13 0.0006
435 PARANOIA 10 0.0006
436 NERVOUS SYSTEM DISORDER 18 0.0006
437 SLEEP APNOEA SYNDROME 11 0.0006
438 PANIC ATTACK 21 0.0006
439 HYPERTENSION 122 0.0006
440 HYPERTRANSAMINASAEMIA 4 0.0006
441 TONSILLITIS 3 0.0006
442 CARPAL TUNNEL SYNDROME 8 0.0006
443 FLUID RETENTION 29 0.0006
444 DEPRESSED MOOD 30 0.0006
445 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
446 LYMPHADENOPATHY 20 0.0006
447 PHARYNGITIS 7 0.0006
448 FOOD POISONING 3 0.0006
449 COMPRESSION FRACTURE 3 0.0006
450 HIP FRACTURE 18 0.0006
451 BACK PAIN 130 0.0006
452 PARALYSIS 8 0.0006
453 DYSPHAGIA 53 0.0006
454 HAEMARTHROSIS 5 0.0006
455 TREATMENT FAILURE 46 0.0006
456 HYPERTHYROIDISM 8 0.0006
457 MUSCLE ATROPHY 7 0.0006
458 OPTIC NEURITIS 5 0.0005
459 MAJOR DEPRESSION 4 0.0005
460 ADVERSE DRUG REACTION 49 0.0005
461 ROTATOR CUFF SYNDROME 7 0.0005
462 DENTAL CARIES 6 0.0005
463 FEEDING DISORDER 11 0.0005
464 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
465 DRUG WITHDRAWAL SYNDROME NEONATAL 8 0.0005
466 VENTRICULAR FIBRILLATION 6 0.0005
467 COAGULOPATHY 9 0.0005
468 PERSONALITY CHANGE 5 0.0005
469 MALNUTRITION 6 0.0005
470 WEIGHT INCREASED 120 0.0005
471 APPENDICITIS 5 0.0005
472 HYDRONEPHROSIS 4 0.0005
473 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
474 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
475 BEDRIDDEN 7 0.0005
476 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
477 SUICIDE ATTEMPT 32 0.0005
478 HYPERSENSITIVITY 97 0.0005
479 LIPASE INCREASED 4 0.0005
480 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
481 CHOLESTASIS 10 0.0005
482 OROPHARYNGEAL PAIN 48 0.0005
483 FEMUR FRACTURE 16 0.0005
484 HYPOVOLAEMIA 3 0.0005
485 SPLENOMEGALY 6 0.0005
486 MULTIPLE ALLERGIES 4 0.0005
487 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
488 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
489 HEAD DISCOMFORT 9 0.0005
490 MATERNAL EXPOSURE DURING PREGNANCY 45 0.0005
491 BLADDER DISORDER 5 0.0005
492 GOUT 9 0.0005
493 PREMATURE BABY 15 0.0005
494 HEPATITIS CHOLESTATIC 3 0.0005
495 DRUG INTOLERANCE 48 0.0005
496 SENSORY LOSS 4 0.0005
497 SLEEP DISORDER 35 0.0005
498 MYALGIA 84 0.0005
499 SCHIZOPHRENIA 6 0.0005
500 INGUINAL HERNIA 3 0.0005
501 INITIAL INSOMNIA 5 0.0005
502 CHROMATURIA 11 0.0005
503 PRODUCT AVAILABILITY ISSUE 11 0.0005
504 LIVER FUNCTION TEST ABNORMAL 14 0.0005
505 PRE-EXISTING CONDITION IMPROVED 3 0.0005
506 TRANSFUSION 5 0.0005
507 MOOD ALTERED 13 0.0005
508 BLOOD URINE PRESENT 9 0.0005
509 SUDDEN DEATH 5 0.0005
510 BLOOD CHOLESTEROL INCREASED 22 0.0005
511 GALACTORRHOEA 3 0.0005
512 NIGHT SWEATS 15 0.0005
513 CARDIAC OPERATION 4 0.0005
514 HYPERPROLACTINAEMIA 3 0.0005
515 ANGINA UNSTABLE 3 0.0005
516 THROMBOCYTOPENIA 51 0.0005
517 SARS-COV-2 TEST POSITIVE 6 0.0005
518 CORONAVIRUS INFECTION 3 0.0005
519 APPETITE DISORDER 3 0.0005
520 DRUG ERUPTION 8 0.0005
521 RASH 196 0.0004
522 GAIT INABILITY 15 0.0004
523 MYOCARDIAL INFARCTION 78 0.0004
524 MYOCARDIAL ISCHAEMIA 5 0.0004
525 PYREXIA 152 0.0004
526 MICTURITION URGENCY 5 0.0004
527 RETINAL DETACHMENT 4 0.0004
528 NEOPLASM 5 0.0004
529 PRODUCT COMPLAINT 11 0.0004
530 LYMPHOEDEMA 3 0.0004
531 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
532 MENTAL STATUS CHANGES 12 0.0004
533 FATIGUE 336 0.0004
534 PRODUCT DISTRIBUTION ISSUE 4 0.0004
535 CAESAREAN SECTION 5 0.0004
536 THINKING ABNORMAL 8 0.0004
537 CORONARY ARTERY DISEASE 13 0.0004
538 ERECTILE DYSFUNCTION 11 0.0004
539 ASTHENIA 160 0.0004
540 MANIA 7 0.0004
541 ARTERIOSCLEROSIS 4 0.0004
542 ATAXIA 5 0.0004
543 HEADACHE 264 0.0004
544 PRODUCT PACKAGING ISSUE 4 0.0004
545 PRODUCT SUPPLY ISSUE 3 0.0004
546 LEUKOPENIA 21 0.0004
547 MYOCLONUS 5 0.0004
548 ANGINA PECTORIS 12 0.0004
549 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
550 RASH PUSTULAR 3 0.0004
551 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
552 ORAL DISORDER 3 0.0004
553 ENCEPHALOPATHY 10 0.0004
554 BLOOD BILIRUBIN INCREASED 11 0.0004
555 FEELING DRUNK 3 0.0004
556 LACTIC ACIDOSIS 13 0.0004
557 GENERAL SYMPTOM 3 0.0004
558 SALIVARY HYPERSECRETION 4 0.0004
559 BRAIN INJURY 4 0.0004
560 EXTRA DOSE ADMINISTERED 16 0.0004
561 AORTIC ANEURYSM 3 0.0004
562 CARDIOVASCULAR DISORDER 10 0.0004
563 EPILEPSY 12 0.0004
564 GASTROINTESTINAL DISORDER 35 0.0004
565 MALAISE 170 0.0004
566 TENDONITIS 6 0.0004
567 ABDOMINAL DISCOMFORT 65 0.0004
568 CONCUSSION 3 0.0004
569 NAUSEA 306 0.0004
570 DRUG INTERACTION 61 0.0004
571 HAEMORRHAGIC STROKE 3 0.0004
572 TENDERNESS 4 0.0004
573 WEIGHT FLUCTUATION 4 0.0004
574 AFFECTIVE DISORDER 3 0.0004
575 HYPERHIDROSIS 49 0.0004
576 HALLUCINATION, VISUAL 8 0.0004
577 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
578 BLOOD ALBUMIN DECREASED 3 0.0004
579 EATING DISORDER 8 0.0004
580 RETCHING 8 0.0004
581 STENT PLACEMENT 3 0.0004
582 POOR QUALITY SLEEP 8 0.0004
583 MUSCLE DISORDER 3 0.0004
584 POST PROCEDURAL INFECTION 3 0.0004
585 BACK INJURY 4 0.0004
586 PALPITATIONS 43 0.0004
587 CONDITION AGGRAVATED 111 0.0004
588 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
589 ABDOMINAL DISTENSION 38 0.0004
590 GASTROINTESTINAL PAIN 4 0.0004
591 VENTRICULAR TACHYCARDIA 6 0.0004
592 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
593 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
594 INFUSION RELATED REACTION 24 0.0004
595 HERNIA 7 0.0004
596 CYTOMEGALOVIRUS INFECTION 6 0.0004
597 VERTIGO 22 0.0004
598 HEMIPLEGIA 3 0.0004
599 ROAD TRAFFIC ACCIDENT 15 0.0004
600 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
601 CHILLS 42 0.0004
602 ATRIAL SEPTAL DEFECT 3 0.0004
603 PANCYTOPENIA 20 0.0004
604 SNEEZING 8 0.0004
605 PANCREATITIS ACUTE 8 0.0004
606 SKIN REACTION 5 0.0004
607 EYE INFECTION 4 0.0004
608 SEASONAL ALLERGY 5 0.0004
609 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
610 DIALYSIS 5 0.0004
611 CHOLECYSTECTOMY 4 0.0003
612 PSEUDOMONAS INFECTION 3 0.0003
613 GASTRIC DISORDER 12 0.0003
614 HEPATIC FUNCTION ABNORMAL 13 0.0003
615 SKIN DISCOLOURATION 16 0.0003
616 PYELONEPHRITIS 3 0.0003
617 ANAEMIA 66 0.0003
618 SEXUAL DYSFUNCTION 4 0.0003
619 ILLNESS 35 0.0003
620 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
621 CARDIOMYOPATHY 5 0.0003
622 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
623 RHABDOMYOLYSIS 14 0.0003
624 ABDOMINAL PAIN 78 0.0003
625 ANAL INCONTINENCE 3 0.0003
626 OSTEOMYELITIS 6 0.0003
627 CARDIAC DISORDER 31 0.0003
628 SKIN DISORDER 11 0.0003
629 PRESYNCOPE 8 0.0003
630 SEIZURE 38 0.0003
631 INSURANCE ISSUE 5 0.0003
632 RESPIRATORY DISTRESS 9 0.0003
633 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
634 VOMITING 152 0.0003
635 GYNAECOMASTIA 10 0.0003
636 GENERALISED OEDEMA 4 0.0003
637 FAECES DISCOLOURED 7 0.0003
638 MIDDLE INSOMNIA 6 0.0003
639 SECRETION DISCHARGE 4 0.0003
640 FLATULENCE 18 0.0003
641 ABDOMINAL PAIN UPPER 65 0.0003
642 NEUROPATHY PERIPHERAL 30 0.0003
643 MUSCULOSKELETAL DISORDER 6 0.0003
644 DISTURBANCE IN ATTENTION 17 0.0003
645 OBESITY 5 0.0003
646 SCIATICA 5 0.0003
647 RASH PAPULAR 7 0.0003
648 INTENTIONAL OVERDOSE 20 0.0003
649 HYPERCHOLESTEROLAEMIA 3 0.0003
650 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
651 HEART RATE IRREGULAR 7 0.0003
652 DIARRHOEA 199 0.0003
653 AUTOIMMUNE DISORDER 3 0.0003
654 NASAL CONGESTION 18 0.0003
655 LUNG DISORDER 15 0.0003
656 KIDNEY INFECTION 6 0.0003
657 DECREASED APPETITE 71 0.0003
658 LABORATORY TEST ABNORMAL 9 0.0003
659 LIGAMENT SPRAIN 3 0.0003
660 SOMNOLENCE 61 0.0003
661 CHEST PAIN 56 0.0003
662 HYPONATRAEMIA 17 0.0003
663 ASTHMA 34 0.0003
664 BLOOD UREA INCREASED 5 0.0003
665 JOINT RANGE OF MOTION DECREASED 4 0.0003
666 JOINT SWELLING 36 0.0003
667 EMPHYSEMA 3 0.0003
668 TYPE 2 DIABETES MELLITUS 10 0.0003
669 COUGH 83 0.0003
670 HERPES ZOSTER 17 0.0003
671 ANGIOEDEMA 13 0.0003
672 PARAESTHESIA 46 0.0003
673 EAR DISCOMFORT 3 0.0003
674 HAEMATURIA 10 0.0003
675 HELICOBACTER INFECTION 3 0.0003
676 CORONARY ARTERY OCCLUSION 4 0.0003
677 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
678 ARTHRALGIA 121 0.0003
679 TEMPERATURE INTOLERANCE 3 0.0003
680 DELIRIUM 10 0.0003
681 NEURALGIA 7 0.0003
682 NERVOUSNESS 15 0.0003
683 WEIGHT DECREASED 80 0.0003
684 DEMENTIA 8 0.0003
685 INCONTINENCE 3 0.0003
686 IRRITABILITY 17 0.0003
687 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
688 MOOD SWINGS 9 0.0003
689 HYPOAESTHESIA 42 0.0003
690 BODY HEIGHT DECREASED 3 0.0003
691 ISCHAEMIC STROKE 5 0.0003
692 INFLUENZA LIKE ILLNESS 23 0.0003
693 HYPERSOMNIA 8 0.0003
694 RHINORRHOEA 18 0.0003
695 PRURITUS GENERALISED 6 0.0003
696 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 50 0.0003
697 ANOSMIA 4 0.0003
698 CRYING 10 0.0003
699 DYSPEPSIA 27 0.0003
700 APATHY 4 0.0003
701 ACCIDENTAL OVERDOSE 10 0.0003
702 LOSS OF CONSCIOUSNESS 35 0.0003
703 RHEUMATOID ARTHRITIS 31 0.0003
704 UNRESPONSIVE TO STIMULI 7 0.0003
705 BLINDNESS 11 0.0003
706 STEVENS-JOHNSON SYNDROME 6 0.0003
707 TOOTH DISORDER 6 0.0003
708 EYE PRURITUS 9 0.0003
709 JOINT STIFFNESS 7 0.0003
710 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
711 HEPATIC FAILURE 8 0.0003
712 MITRAL VALVE INCOMPETENCE 3 0.0003
713 PAIN IN EXTREMITY 78 0.0003
714 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
715 PULMONARY EMBOLISM 25 0.0003
716 SCAB 3 0.0003
717 DIZZINESS 131 0.0003
718 ACIDOSIS 2 0.0003
719 CARDIAC FAILURE 21 0.0003
720 AMNESIA 17 0.0003
721 PHARYNGEAL OEDEMA 4 0.0003
722 EMOTIONAL DISORDER 8 0.0003
723 TACHYCARDIA 23 0.0003
724 MUSCULOSKELETAL CHEST PAIN 4 0.0003
725 CONSTIPATION 56 0.0003
726 SURGERY 15 0.0003
727 HYPOXIA 9 0.0003
728 BRAIN FOG 4 0.0003
729 FEELING ABNORMAL 61 0.0003
730 ARTHRITIS 20 0.0003
731 PRODUCT PRESCRIBING ERROR 6 0.0003
732 FEELING COLD 7 0.0003
733 BLISTER 14 0.0002
734 PRODUCT ADMINISTRATION ERROR 5 0.0002
735 HYPERGLYCAEMIA 9 0.0002
736 MUSCLE TIGHTNESS 4 0.0002
737 RESPIRATORY FAILURE 18 0.0002
738 CEREBRAL INFARCTION 6 0.0002
739 BODY TEMPERATURE INCREASED 5 0.0002
740 CARDIOMEGALY 3 0.0002
741 SPINAL OPERATION 3 0.0002
742 BRONCHITIS 18 0.0002
743 HYPERCALCAEMIA 3 0.0002
744 ABNORMAL WEIGHT GAIN 3 0.0002
745 TOOTH EXTRACTION 3 0.0002
746 MEMORY IMPAIRMENT 33 0.0002
747 RASH PRURITIC 13 0.0002
748 MUSCLE SPASMS 44 0.0002
749 NEOPLASM MALIGNANT 16 0.0002
750 HYPOKALAEMIA 11 0.0002
751 BRAIN OEDEMA 3 0.0002
752 FACE OEDEMA 4 0.0002
753 HEMIPARESIS 4 0.0002
754 IRRITABLE BOWEL SYNDROME 5 0.0002
755 INJECTION SITE INDURATION 3 0.0002
756 CEREBROVASCULAR ACCIDENT 39 0.0002
757 MUSCULOSKELETAL PAIN 12 0.0002
758 COMPLETED SUICIDE 19 0.0002
759 NEUTROPENIA 31 0.0002
760 ADVERSE EVENT 21 0.0002
761 IMMUNE SYSTEM DISORDER 3 0.0002
762 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
763 LETHARGY 13 0.0002
764 RASH MACULO-PAPULAR 5 0.0002
765 GALLBLADDER DISORDER 4 0.0002
766 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
767 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
768 TOOTHACHE 4 0.0002
769 LIMB INJURY 6 0.0002
770 TACHYPNOEA 3 0.0002
771 GINGIVAL BLEEDING 3 0.0002
772 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
773 CELLULITIS 11 0.0002
774 ORAL DISCOMFORT 3 0.0002
775 HUNGER 3 0.0002
776 PSORIASIS 28 0.0002
777 BLOOD TEST ABNORMAL 3 0.0002
778 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
779 SINUS TACHYCARDIA 3 0.0002
780 MIGRAINE 20 0.0002
781 IMPAIRED QUALITY OF LIFE 3 0.0002
782 DIABETIC KETOACIDOSIS 5 0.0002
783 INFECTION 30 0.0002
784 ANGER 7 0.0002
785 HYPOKINESIA 3 0.0002
786 INFLUENZA 23 0.0002
787 EAR PAIN 4 0.0002
788 CHEST DISCOMFORT 21 0.0002
789 HAEMORRHOIDS 4 0.0002
790 ABASIA 5 0.0002
791 DISORIENTATION 8 0.0002
792 COLON CANCER 3 0.0002
793 PERIPHERAL SWELLING 31 0.0002
794 HAEMORRHAGE INTRACRANIAL 3 0.0002
795 RASH MACULAR 7 0.0002
796 ERYTHEMA 41 0.0002
797 HYPOTENSION 40 0.0002
798 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
799 DISCOMFORT 12 0.0002
800 NEUTROPHIL COUNT DECREASED 8 0.0002
801 INJECTION SITE WARMTH 4 0.0002
802 LIMB DISCOMFORT 6 0.0002
803 MUSCULAR WEAKNESS 22 0.0002
804 DYSPNOEA 109 0.0002
805 PULMONARY HYPERTENSION 4 0.0002
806 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
807 AGITATION 14 0.0002
808 KNEE ARTHROPLASTY 4 0.0002
809 DISEASE RECURRENCE 9 0.0002
810 RECTAL HAEMORRHAGE 8 0.0002
811 DYSARTHRIA 7 0.0002
812 HALLUCINATION 14 0.0002
813 INJURY 13 0.0002
814 PRURITUS 71 0.0002
815 SWELLING FACE 12 0.0002
816 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
817 CHOLELITHIASIS 6 0.0002
818 IMPAIRED HEALING 6 0.0002
819 PHOTOSENSITIVITY REACTION 3 0.0002
820 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
821 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
822 SEPSIS 20 0.0002
823 NASOPHARYNGITIS 33 0.0002
824 NECK PAIN 10 0.0002
825 EYE PAIN 10 0.0002
826 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
827 CIRCULATORY COLLAPSE 3 0.0002
828 MUSCULOSKELETAL DISCOMFORT 3 0.0002
829 MUSCLE TWITCHING 4 0.0002
830 UNEVALUABLE EVENT 13 0.0002
831 OVERDOSE 37 0.0002
832 EOSINOPHILIA 3 0.0002
833 DYSPHONIA 10 0.0002
834 SWELLING 16 0.0002
835 LYMPHOCYTE COUNT DECREASED 3 0.0002
836 CEREBRAL HAEMORRHAGE 6 0.0002
837 ACCIDENT 2 0.0002
838 BLOOD PRESSURE FLUCTUATION 4 0.0002
839 GASTROENTERITIS VIRAL 3 0.0002
840 PELVIC PAIN 3 0.0002
841 DEHYDRATION 22 0.0002
842 DEATH 142 0.0002
843 ADRENAL INSUFFICIENCY 2 0.0002
844 BLOOD GLUCOSE INCREASED 31 0.0002
845 RESTLESSNESS 6 0.0002
846 PNEUMONIA 53 0.0002
847 FEELING HOT 10 0.0002
848 HAEMATOCHEZIA 9 0.0002
849 HAEMORRHAGE 17 0.0002
850 INJECTION SITE MASS 6 0.0002
851 BALANCE DISORDER 14 0.0002
852 BACTERIAL INFECTION 3 0.0002
853 AGGRESSION 8 0.0002
854 PHOTOPHOBIA 3 0.0002
855 CARDIAC ARREST 13 0.0002
856 FEELING JITTERY 3 0.0002
857 PULMONARY OEDEMA 7 0.0002
858 URTICARIA 26 0.0002
859 ANAPHYLACTIC SHOCK 4 0.0002
860 DIPLOPIA 4 0.0002
861 DEAFNESS 4 0.0002
862 HEART RATE INCREASED 15 0.0002
863 BLOOD PRESSURE ABNORMAL 3 0.0002
864 ADVERSE REACTION 2 0.0002
865 LIP SWELLING 5 0.0001
866 FULL BLOOD COUNT DECREASED 3 0.0001
867 INTENTIONAL SELF-INJURY 3 0.0001
868 CONFUSIONAL STATE 24 0.0001
869 THERAPEUTIC RESPONSE DECREASED 9 0.0001
870 FREQUENT BOWEL MOVEMENTS 4 0.0001
871 ARRHYTHMIA 7 0.0001
872 OCULAR HYPERAEMIA 7 0.0001
873 PRODUCT PREPARATION ERROR 3 0.0001
874 SKIN LESION 4 0.0001
875 TREMOR 24 0.0001
876 INTERSTITIAL LUNG DISEASE 7 0.0001
877 DIVERTICULITIS 4 0.0001
878 ARTHROPATHY 8 0.0001
879 MEDICATION ERROR 8 0.0001
880 PLATELET COUNT DECREASED 15 0.0001
881 JOINT INJURY 3 0.0001
882 PRODUCT QUALITY ISSUE 19 0.0001
883 PRODUCT SUBSTITUTION ISSUE 8 0.0001
884 ALOPECIA 27 0.0001
885 ASCITES 4 0.0001
886 FEBRILE NEUTROPENIA 9 0.0001
887 INFLAMMATION 7 0.0001
888 THERAPY NON-RESPONDER 6 0.0001
889 FALL 44 0.0001
890 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
891 COLITIS 5 0.0001
892 COVID-19 23 0.0001
893 TINNITUS 6 0.0001
894 DRUG ADMINISTRATION ERROR 4 0.0001
895 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
896 BURNING SENSATION 9 0.0001
897 INCORRECT DOSE ADMINISTERED 29 0.0001
898 HEAD INJURY 4 0.0001
899 THROMBOSIS 10 0.0001
900 MENTAL IMPAIRMENT 3 0.0001
901 UNDERDOSE 9 0.0001
902 EYE DISORDER 4 0.0001
903 FUNGAL INFECTION 4 0.0001
904 HOT FLUSH 9 0.0001
905 ABDOMINAL PAIN LOWER 3 0.0001
906 GASTRIC CANCER 3 0.0001
907 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
908 RESPIRATORY TRACT INFECTION 3 0.0001
909 SPEECH DISORDER 6 0.0001
910 MUSCULOSKELETAL STIFFNESS 10 0.0001
911 ATRIAL FIBRILLATION 11 0.0001
912 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
913 THERAPY INTERRUPTED 8 0.0001
914 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
915 SYNCOPE 11 0.0001
916 RESPIRATORY ARREST 3 0.0001
917 DRUG INEFFECTIVE 143 0.0001
918 DYSGEUSIA 8 0.0001
919 AGRANULOCYTOSIS 2 0.0001
920 SINUSITIS 11 0.0001
921 COGNITIVE DISORDER 5 0.0001
922 SKIN EXFOLIATION 9 0.0001
923 DYSPNOEA EXERTIONAL 4 0.0001
924 INTESTINAL OBSTRUCTION 4 0.0001
925 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
926 COMA 5 0.0001
927 RED BLOOD CELL COUNT DECREASED 3 0.0001
928 PRODUCTIVE COUGH 5 0.0001
929 ACUTE RESPIRATORY FAILURE 2 0.0001
930 PANCREATIC CARCINOMA 3 0.0001
931 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
932 CATARACT 6 0.0001
933 RESPIRATORY DISORDER 3 0.0001
934 BLOOD POTASSIUM DECREASED 3 0.0001
935 OFF LABEL USE 87 0.0001
936 PLEURAL EFFUSION 6 0.0001
937 PSORIATIC ARTHROPATHY 4 0.0001
938 INJECTION SITE PAIN 30 0.0001
939 LUNG NEOPLASM MALIGNANT 4 0.0001
940 VISUAL IMPAIRMENT 12 0.0001
941 SWOLLEN TONGUE 3 0.0001
942 CARDIO-RESPIRATORY ARREST 4 0.0001
943 ECZEMA 5 0.0001
944 DERMATITIS ATOPIC 5 0.0001
945 EPISTAXIS 7 0.0001
946 MOVEMENT DISORDER 3 0.0001
947 HYPOACUSIS 4 0.0001
948 DEEP VEIN THROMBOSIS 6 0.0001
949 OEDEMA 5 0.0001
950 SEPTIC SHOCK 4 0.0001
951 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
952 STAPHYLOCOCCAL INFECTION 3 0.0001
953 OEDEMA PERIPHERAL 11 0.0001
954 URINARY TRACT INFECTION 15 0.0001
955 WHEEZING 5 0.0001
956 DRUG ABUSE 7 0.0001
957 SKIN BURNING SENSATION 6 0.0001
958 TOXICITY TO VARIOUS AGENTS 14 0.0001
959 NO ADVERSE EVENT 15 0.0001
960 DRUG EFFECT INCOMPLETE 3 0.0001
961 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
962 EYE SWELLING 3 0.0001
963 AGEUSIA 2 0.0001
964 DRY EYE 4 0.0001
965 ABNORMAL BEHAVIOUR 3 0.0001
966 DRUG EFFECT DECREASED 4 0.0001
967 WITHDRAWAL SYNDROME 3 0.0001
968 HAEMOGLOBIN DECREASED 7 0.0001
969 THROAT IRRITATION 3 0.0001
970 STOMATITIS 4 0.0001
971 ACNE 5 0.0001
972 BLOOD PRESSURE INCREASED 10 0.0001
973 INJECTION SITE SWELLING 5 0.0001
974 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
975 BLOOD GLUCOSE DECREASED 3 0.0001
976 CONTUSION 6 0.0001
977 HYPOGLYCAEMIA 3 0.0001
978 DRY MOUTH 5 0.0001
979 VISION BLURRED 8 0.0001
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
981 OXYGEN SATURATION DECREASED 3 0.0001
982 DRY SKIN 7 0.0001
983 EYE IRRITATION 3 0.0001
984 DISEASE PROGRESSION 6 0.0001
985 CARDIAC FAILURE CONGESTIVE 4 0.0000
986 FLUSHING 5 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
988 DRUG DEPENDENCE 5 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
990 INJECTION SITE ERYTHEMA 3 0.0000